Dr. Abdul Kadir Slocum M.D. is originally from the United States, but grew up in Turkey and completed his medical training at Marmara University, Istanbul. He is an oncologist dedicated to improving his patients’ outcomes with innovative treatment modalities and integrative therapeutic approaches. Drawing on his many years’ experience, he combines evidence-based complementary and metabolic therapies with conventional cancer treatments for optimal patient outcomes.

Dr. Slocum believes in treating the whole person, addressing not only the physical aspects of cancer but also the emotional, psychological, and spiritual dimensions. He recognizes that a cancer diagnosis can have a profound impact on a patient’s overall health and quality of life, and he is dedicated to providing comprehensive care that supports the body, mind, and spirit.

In his practice, Dr. Slocum integrates complementary and metabolic therapies such as hyperthermia, hyperbaric oxygen therapy, ozone therapy, repurposed drugs, ketogenic diet and other metabolic therapies into personalized treatment plans and keeps up-to-date with the latest research to deliver the latest evidence-based practice. He values transparent communication with his patients and involves them in shared decision-making, empowering them throughout their journeys.

Beyond his clinical work, Dr. Slocum contributes to research and community outreach, raising awareness and increasing education about integrative oncology and metabolic cancer treatment. With his commitment to patient-centered care and the integration of conventional cancer treatment with science-based complementary and metabolic therapies, Dr. Slocum continually strives to improve his patients’ well-being and treatment outcomes.

Prof. Didem Taştekin, M.D., graduated from Selçuk University Faculty of Medicine in 1992. She completed her residency in Internal Medicine at Atatürk University in Erzurum, later serving as an Internal Medicine specialist and Associate Dean at Kafkas University. She went on to complete her medical oncology fellowship at Selçuk University and continued her subspecialty training at the Istanbul University Oncology Institute.

Appointed as Associate Professor in 2012 and Professor in 2023, Prof. Taştekin has dedicated her career to improving outcomes for patients with a variety of cancers. Her main clinical and research interests include pancreatic and hepatocellular cancers, lung cancer, breast cancer, colon cancer and personalized treatment approaches. She has led and contributed to numerous national and international clinical trials and translational research projects, and supportive care in oncology.

Prof. Taştekin is the author or co-author of more than 50 peer-reviewed publications and recent book chapters on innovative concepts in medical oncology, including high-dose vitamin C, extracellular vesicles, and novel systemic treatment strategies. Her work has helped refine prognostic models, identify new biomarkers, and generate real-world evidence in cancers of the pancreas, stomach, liver, and colon.

Known for her compassionate, patient-centered approach, she is an active member of the Anatolian Society of Medical Oncology, the Turkish Society of Medical Oncology, ESMO, and ASCO. She remains committed to integrating cutting-edge science into daily practice to offer her patients individualized, evidence-based cancer care.

Assoc. Prof. Dr. Utku Mahir Yıldırım was born in Ankara in 1978. He completed all his schooling in Ankara and studied at Ankara University Faculty of Medicine between 1997 and 2003. He then received his specialty training in Radiology at Başkent University Faculty of Medicine from 2004 to 2009.

He began his career in January 2010 as a radiology specialist in the Interventional Radiology Unit of the Radiology Clinic at Ankara Yıldırım Beyazıt Training and Research Hospital. From 2012 to 2023, he worked in the Interventional Radiology Department of İzmir Medical Park Hospital. During this period, he also contributed to medical education, first as an Assistant Professor in the Radiology Department of İzmir University Faculty of Medicine and later as an Associate Professor at the Faculty of Medicine of İzmir University of Economics.

Dr. Yıldırım played a key role in introducing the chemosaturation method in Turkey. Since 2019, he has been providing training and proctoring to centers across the country that are newly implementing this technique. He is considered among the most experienced practitioners of chemosaturation in Europe. As the first physician to use LIOX in both Europe and Turkey, he also offers training in this treatment modality. In addition, as the interventional radiologist who first introduced radioembolization to a private hospital in the Aegean region, he has been a pioneer in the adoption of innovative methods in interventional oncology.